医中誌リンクサービス


文献リスト

1)Gasser C, Gautier E, Steck A, et al. Hemolytic-uremic syndrome: bilateral necrosis of the renal cortex in acute acquired hemolytic anemia. Schweiz Med Wochenschr. 1955; 85: 905-9
PubMed
医中誌リンクサービス
2)Moake JL. Thrombotic microangiopathies. N Engl J Med. 2002; 347: 589-600
PubMed CrossRef
医中誌リンクサービス
3)Furlan M, Robles R, Galbusera M, et al. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med. 1998; 339: 1578-84
PubMed CrossRef
医中誌リンクサービス
4)Tsai HM, Lian EC. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med. 1998; 339: 1585-94
PubMed CrossRef
医中誌リンクサービス
5)松本雅則.非典型溶血性尿毒症症候群.In: 高久史麿,他編.Annual Review 血液.2011年度版.東京: 中外医学社; 2011. p.174-81
医中誌リンクサービス
6)George JN, Nester CM. Syndromes of thrombotic microangiopathy. N Engl J Med. 2014; 371: 654-66
PubMed CrossRef
医中誌リンクサービス
7)Scotland SM, Willshaw GA, Smith HR, et al. Properties of strains of Escherichia coli belonging to serogroup O157 with special reference to production of Vero cytotoxins VT1 and VT2. Epidemiol Infect. 1987; 99: 613-24
PubMed CrossRef
医中誌リンクサービス
8)Zoja C, Angioletti S, Donadelli R, et al. Shiga toxin-2 triggers endothelial leukocyte adhesion and transmigration via NF-kappaB dependent up-regulation of IL-8 and MCP-1. Kidney Int. 2002; 62: 846-56
PubMed CrossRef
医中誌リンクサービス
9)Karpman D, Papadopoulou D, Nilsson K, et al. Platelet activation by Shiga toxin and circulatory factors as a pathogenetic mechanism in the hemolytic uremic syndrome. Blood. 2001; 97: 3100-8
PubMed CrossRef
医中誌リンクサービス
10)Lo NC, Turner NA, Cruz MA, et al. Interaction of Shiga toxin with the A-domains and multimers of von Willebrand Factor. J Biol Chem. 2013; 288: 33118-23
PubMed CrossRef
医中誌リンクサービス
11)Aka JA, Jalacic S, Ciol MA, et al. Relative nephroprotection during Escherichia coli O157: H7 infections: Association with intravenous volume expansion. Pediatrics. 2005; 115: e673-80
PubMed CrossRef
医中誌リンクサービス
12)Hickey CA, Beattie TJ, Cowieson J, et al. Early volume expansion during diarrhea and relative nephroprotection during subsequent hemolytic uremic syndrome. Arch Pediatr Adolesc Med. 2011; 165: 884-9
PubMed CrossRef
医中誌リンクサービス
13)上田恭典.血栓性血小板減少性紫斑病と溶血性尿毒症症候群.日本内科学会雑誌.2009; 98: 1627-33
医中誌リンクサービス
14)Constantinescu AR, Bitzan M, Weiss LS, et al. Non-enteropathic hemolytic uremic syndrome: causes and short-term course. Am J Kidney Dis. 2004; 43: 976-82
PubMed CrossRef
医中誌リンクサービス
15)Ohanian M, Cable C, Halka K. Eculizumab safely reverses neurologic impairment and eliminates need for dialysis in severe atypical hemolytic uremic syndrome. Clin Pharmacol. 2011; 3: 5-12
医中誌リンクサービス
16)Sullivan M, Erlic Z, Hoffmann MM, et al. Epidemiological approach to identifying genetic predispositions for atypical hemolytic uremic syndrome. Ann Hum Genet. 2010; 74: 17-26
PubMed CrossRef
医中誌リンクサービス
17)Stühlinger W, Kourilsky O, Kanfer A, et al. Letter: Haemolytic-uraemic syndrome: evidence for intravascular C3 activation. Lancet. 1974; 2: 788-9
PubMed
医中誌リンクサービス
18)Jozsi M, Licht C, Strobel S, et al. Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency. Blood. 2008; 111: 1512-4
PubMed
医中誌リンクサービス
19)Goicoechea de Jorge E, Harris CL, Esparza-Gordillo J, et al. Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome. Proc Natl Acad Sci USA. 2007; 104: 240-5
PubMed CrossRef
医中誌リンクサービス
20)Fremeaux-Bacchi V, Miller EC, Liszewski MK, et al. Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome. Blood. 2008; 112: 4948-52
PubMed CrossRef
医中誌リンクサービス
21)Jodele S, Licht C, Goebel J, et al. Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy. Blood. 2013; 122: 2003-7
PubMed CrossRef
医中誌リンクサービス
22)Loirat C, Frémeaux-Bacchi V. Atypical hemolytic uremic syndrome. Orphanet J Rare Dis. 2011; 6: 60
PubMed
医中誌リンクサービス
23)Mele C, Remuzzi G, Noris M. Hemolytic uremic syndrome. Semin Immunopathol. 2014; 36: 399-420
CrossRef
医中誌リンクサービス
24)Lemaire M, Fremeaux-Bacchi V, Schaefer F, et al. Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome. Nat Genet. 2013; 45: 531-6
PubMed CrossRef
医中誌リンクサービス
25)Sawai T, Nangaku M, Ashida A, et al. Diagnostic criteria for atypical hemolytic uremic syndrome proposed by the Joint Committee of the Japanese Society of Nephrology and the Japan Pediatric Society. Pediatr Int. 2014; 56: 1-5
医学中央雑誌刊行会  CrossRef
医中誌リンクサービス
26)Feng S, Eyler SJ, Zhang Y, et al. Partial ADAMTS13 deficiency in atypical hemolytic uremic syndrome. Blood. 2013; 122: 1487-93
PubMed CrossRef
医中誌リンクサービス
27)吉田瑶子,藤村吉博.非典型溶血性尿毒症症候群(aHUS)の病態と治療戦略.血液内科.2014(印刷中)
医学中央雑誌刊行会
医中誌リンクサービス
28)Ariceta G, Besbas N, Johnson S, et al. Guidelines for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome. Pediatr Nephrol. 2009; 24: 687-96
PubMed CrossRef
医中誌リンクサービス
29)Dragon-Durey MA, Sethi SK, Bagga A, et al. Clinical features of anti-factor H autoantibody-associated hemolytic uremic syndrome. J Am Soc Nephrol. 2010; 21: 2180-7
PubMed CrossRef
医中誌リンクサービス
30)Gruppo RA, Rother RP. Eculizumab for congenital atypical hemolytic-uremic syndrome. N Engl J Med. 2009; 360: 544-6
PubMed CrossRef
医中誌リンクサービス
31)Nurnberger J, Philipp T, Witzke O, et al. Eculizumab for atypical hemolytic-uremic syndrome. N Engl J Med. 2009; 360: 542-4
PubMed CrossRef
医中誌リンクサービス
32)Legendre CM, Licht C, Muus P, et al. Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. N Engl J Med. 2013; 368: 2169-81
PubMed CrossRef
医中誌リンクサービス
33)Zuber J, Le Quintrec M, Krid S, et al. Eculizumab for atypical hemolytic uremic syndrome recurrence in renal transplantation. Am J Transplant. 2012; 12: 3337-54
PubMed CrossRef
医中誌リンクサービス
34)Jodele S, Fukuda T, Vinks A, et al. Eculizumab therapy in children with severe hematopoietic stem cell transplantation-associated thrombotic microangiopathy. Biol Blood Marrow Transplant. 2014; 20: 518-25
PubMed CrossRef
医中誌リンクサービス


NPO医学中央雑誌刊行会
https://www.jamas.or.jp/
info@jamas.or.jp